| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/18/2007 | WO2006055631A3 Casein kinase stress-related polypeptides and methods of use in plants |
| 05/18/2007 | WO2006047603A3 Ungulates with genetically modified immune systems |
| 05/18/2007 | WO2006042848A9 Growth hormone conjugates |
| 05/18/2007 | WO2006020868A3 Intracellular production of a nuclease |
| 05/18/2007 | WO2006018836A3 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
| 05/18/2007 | WO2005085457A3 Method and products for the selective degradation of proteins |
| 05/18/2007 | WO2005072126A3 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 05/18/2007 | WO2005040334A3 Selective lipases and methods of screening therefor |
| 05/18/2007 | WO2004103275A3 Compositions and methods for the preparation of human growth hormone glycosylation mutants |
| 05/18/2007 | WO2004022593A8 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 05/18/2007 | WO2003076594A3 Genomic screen for epigenetically silenced tumor suppressor genes |
| 05/18/2007 | WO2000040740A3 Gene therapy to promote angiogenesis |
| 05/18/2007 | CA2629978A1 Detection of nucleic acids by target-specific hybrid capture method |
| 05/18/2007 | CA2629388A1 Methods and compositions for the assessment of cardiovascular function and disorders |
| 05/18/2007 | CA2629376A1 Inhibitors of parp activity and uses thereof |
| 05/18/2007 | CA2629284A1 Microprojectile bombardment transformation of brassica |
| 05/18/2007 | CA2629128A1 A soybean root-preferred, nematode-inducible promoter and methods of use |
| 05/18/2007 | CA2629075A1 Herbicide-resistant sunflower plants with a novel mutation in the gene encoding the large subunit of acetohydroxyacid synthase, isolated polynucleotides, and methods of use |
| 05/18/2007 | CA2628941A1 Methods for the identification of microrna and their applications in research and human health |
| 05/18/2007 | CA2628865A1 Methods and compositions for modulation of stem cell aging |
| 05/18/2007 | CA2628552A1 Identification and characterization of function-blocking anti-ed-b-fibronectin antibodies |
| 05/18/2007 | CA2628505A1 Use of armadillo repeat (arm1) polynucleotides for obtaining resistance to pathogens in plants |
| 05/18/2007 | CA2628451A1 Methods for promoting neurite outgrowth and survival of dopaminergic neurons |
| 05/18/2007 | CA2628315A1 Compositions and methods for the detection of trypanosoma cruzi infection |
| 05/18/2007 | CA2628306A1 Immunostimulatory oligonucleotide-based compounds with glycerol-linked dinucleotides and modified guanosines at cpg and uses thereof |
| 05/18/2007 | CA2628113A1 Peptide-dicer substrate rna conjugates as delivery vehicles for sirna |
| 05/18/2007 | CA2627334A1 Enzyme and methodology for the treatment of a biomass |
| 05/18/2007 | CA2627075A1 Antibody ultrahumanization by predicted mature cdr blasting and cohort library generation and screening |
| 05/18/2007 | CA2626891A1 Recombinant expression of multiprotein complexes using polygenes |
| 05/18/2007 | CA2626831A1 Compositions, reagents and kits for and methods of diagnosing, monitoring and treating hormonal imbalance |
| 05/18/2007 | CA2626690A1 Compositions and methods for inhibiting expression of factor v leiden mutant gene |
| 05/18/2007 | CA2626584A1 Compositions and methods for inhibiting expression of nav1.8 gene |
| 05/18/2007 | CA2537783A1 Tumour treatment |
| 05/18/2007 | CA2526296A1 Shuttle vector and use in evaluation of mutation phenomenon |
| 05/17/2007 | US20070113304 Antifreeze proteins isolated from forage grasses and methods for their use |
| 05/17/2007 | US20070113303 Comprises transgenic potato which generates starch with modified viscosity and phosphate characteristics; for enhancing quality of paper, cardboard, adhesive, textile, plaster, concrete, fertilizer, medicine and toothpaste; improving animal feeds |
| 05/17/2007 | US20070113302 Recombinant DNA constructs and methods for controlling gene expression |
| 05/17/2007 | US20070113301 Transgenic plant cells and seeds with improved abiotic and biotic stress tolerance and improved resistance to pests or pathogens |
| 05/17/2007 | US20070113300 Clp-protease as target for herbicides |
| 05/17/2007 | US20070113296 Novel brain-localized protein kinases homologous to homeodomain-interacting protein kinases |
| 05/17/2007 | US20070113295 Gene blocking method |
| 05/17/2007 | US20070112179 Novel compounds |
| 05/17/2007 | US20070111963 Modulation of gene expression by oligomers targeted to chromosomal DNA |
| 05/17/2007 | US20070111962 Immunosuppression compound and treatment method |
| 05/17/2007 | US20070111961 Dbait and uses thereof |
| 05/17/2007 | US20070111959 Combination gene for use in inhibiting cancerous cell growth |
| 05/17/2007 | US20070111958 Antisense IL-4 inhibits viral replication in the liver, lungs, spleen, and even the lymph nodes; can be used in combination with other antiretroviral agents or vaccines |
| 05/17/2007 | US20070111957 Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof |
| 05/17/2007 | US20070111946 Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) |
| 05/17/2007 | US20070111945 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |
| 05/17/2007 | US20070111942 For detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 05/17/2007 | US20070111934 Procaspase 1 activation inhibitor |
| 05/17/2007 | US20070111312 Method for the production of permanent human cell lines |
| 05/17/2007 | US20070111311 Plant cells and plants with increased tolerance to environmental stress |
| 05/17/2007 | US20070111295 Method of Producing Baculovirus |
| 05/17/2007 | US20070111294 Methods and organisms for the growth-coupled production of succinate |
| 05/17/2007 | US20070111293 Genes from a gene cluster |
| 05/17/2007 | US20070111291 Coryneform Bacteria Which Produce Chemical Compounds I |
| 05/17/2007 | US20070111290 Corynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phosphotransferase system proteins |
| 05/17/2007 | US20070111288 Biosynthesis of botulinium toxins by anaerobic fermentation of Clostridium botulin toxins |
| 05/17/2007 | US20070111287 Design of beta-sheet proteins with specific binding properties |
| 05/17/2007 | US20070111286 Express the novel calcium channel subunits; cells may be used for identifying compounds capable of stimulating or inhibiting the activation of the calcium channels |
| 05/17/2007 | US20070111285 Human skeletal muscle-specific ubiquitin-conjugating emzyme |
| 05/17/2007 | US20070111284 Galactosylation of Recombinant Glycoproteins |
| 05/17/2007 | US20070111283 Vector system for selection of genes encoding secreted proteins and membrane-bound proteins |
| 05/17/2007 | US20070111282 Immunoglobulins; antibodies; complementary determining regions; immunoassay |
| 05/17/2007 | US20070111280 Compositions and methods for non-targeted activation of endogenous genes |
| 05/17/2007 | US20070111278 Endoglucanase stce and cellulase preparation containing the same |
| 05/17/2007 | US20070111277 Identification of 3-ketosteroid 9-alfa-hydroxylase genes and microorganisms blocked in 3-ketosteroid 9-alfa-hydroxylase activity |
| 05/17/2007 | US20070111266 Antibodies to murine zcytor17 ligand |
| 05/17/2007 | US20070111236 Streptococcus suis vaccines and diagnostic tests |
| 05/17/2007 | US20070111232 Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation |
| 05/17/2007 | US20070111230 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport |
| 05/17/2007 | US20070111229 Pathogenicity determinants which can be used as targets for developing means for preventing and controlling bacterial infections and/or systemic dissemination |
| 05/17/2007 | US20070111228 RNA interference |
| 05/17/2007 | US20070111222 Nucleic acid aptamer-based compositions and methods |
| 05/17/2007 | US20070111221 Method of preparation for pharmaceutical grade plasmid DNA |
| 05/17/2007 | US20070111215 Customized oligonucleotide microchips that convert multiple genetic information to simpler patterns, are portable and reusable |
| 05/17/2007 | US20070111212 Method of detecting nucleic acid and utilization thereof |
| 05/17/2007 | US20070111203 Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same |
| 05/17/2007 | US20070111195 Toxicity typing using liver stem cells |
| 05/17/2007 | US20070111193 Selective incorporation of 5-hydroxytryptophan into proteins in mammalian cells |
| 05/17/2007 | US20070111192 Detection of protein interactions |
| 05/17/2007 | US20070110767 An immunogenic mixture of a vector that contains and expresses in vivo in a porcine host cell and a nucleic acid molecule or fragment thereof encoding a porcine circovirus type B antigen |
| 05/17/2007 | US20070110766 Proteinase K resistant surface protein of neisseria meningitidis |
| 05/17/2007 | US20070110765 Helicobacter pylori bacterioferritin |
| 05/17/2007 | US20070110764 Purified polypeptide having the amino acid sequence as set forth in SEQ ID NO: 6; DNA molecules that encode for proteins, BigL1, BigL2 and BigL3 in the Leptospira sp bacterium; diagnostic, therapeutic and vaccine applications; leptospirosis; spirochetesveterinary medicine; humans |
| 05/17/2007 | US20070110763 Polypeptides of streptococcus pyogenes |
| 05/17/2007 | US20070110761 Protein purification means |
| 05/17/2007 | US20070110744 Lymphatic and blood endothelial cell genes |
| 05/17/2007 | US20070110742 Recombinant peptide vector comprising the gene for treatment for autoimmune diseases |
| 05/17/2007 | US20070110736 Mixture comprising mannitol for suspending animal or human cells and for dissolving biologically active molecules in order to introduce molecules into cells using electric current |
| 05/17/2007 | US20070110735 administering to the heart of subject in need of increased capillary density in the heart a trk receptor ligand in an amount effective to increase capillary density in the heart, said trk receptor ligand being selected from the group consisting of brain-derived neurotrophic factor, NT-3, and NT-4. |
| 05/17/2007 | US20070110733 Compositions and methods for stem cell delivery |
| 05/17/2007 | US20070110730 Multipotent stem cells from peripheral tissues and uses thereof |
| 05/17/2007 | US20070110724 DNA viral plasmid for use as gene transfer tool in genetic engineering and genic therapy; improved exogenous transcriptional expression |
| 05/17/2007 | US20070110723 Delivery of trefoil peptides |
| 05/17/2007 | US20070110722 Methods and compositions for the Synthesis of RNA and DNA |
| 05/17/2007 | US20070110721 Plasmid maintenance |
| 05/17/2007 | US20070110720 Vectors, mutant viruses and methods for generating mutant viruses |